BriaCell Therapeutics Corp (TSE:BCT)

BriaCell Therapeutics (BCT) Financial Statements


BriaCell Therapeutics Financial Overview

BriaCell Therapeutics's market cap is currently ―. The company's EPS TTM is C$-2.259; its P/E ratio is -1.27; BriaCell Therapeutics is scheduled to report earnings on October 24, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Jan 24Oct 23Jul 23Apr 23Jan 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -11.33M$ 5.96M$ -2.42M$ -5.68M$ -12.12M
EBITDA$ -11.33M$ 5.96M$ -2.41M$ -5.67M$ -12.12M
Net Income Common Stockholders$ -11.29M$ 6.00M$ -2.42M--
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.24M$ 13.65M$ 21.25M$ 0.00$ 0.00
Total Assets$ 12.23M$ 18.62M$ 27.16M--
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -6.24M$ -13.65M$ -21.25M$ 0.00$ 0.00
Total Liabilities$ 20.55M$ 16.10M$ 30.94M--
Stockholders Equity$ -8.07M$ 2.72M$ -3.78M$ 0.00$ 0.00
Cash Flow-
Free Cash Flow$ -7.40M--$ -5.33M$ -3.95M
Operating Cash Flow$ -7.40M$ -7.61M---
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

BriaCell Therapeutics Earnings and Revenue History

BriaCell Therapeutics Debt to Assets

BriaCell Therapeutics Cash Flow

BriaCell Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis